These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

85 related items for PubMed ID: 2866421

  • 21. Serum total tryptophan and free tryptophan concentration in Down's syndrome its relation to serum serotonin concentration.
    Hoshino Y, Kaneko M, Yashima Y, Kumashiro H.
    Fukushima J Med Sci; 1980 Jun; 27(1-2):39-51. PubMed ID: 6460675
    [No Abstract] [Full Text] [Related]

  • 22. Alzheimer's disease and Down's syndrome: treating two paths to dementia.
    Weksler ME, Szabo P, Relkin NR, Reidenberg MM, Weksler BB, Coppus AM.
    Autoimmun Rev; 2013 Apr; 12(6):670-3. PubMed ID: 23201920
    [Abstract] [Full Text] [Related]

  • 23. Developmental Expression and Dysregulation of miR-146a and miR-155 in Down's Syndrome and Mouse Models of Down's Syndrome and Alzheimer's Disease.
    Arena A, Iyer AM, Milenkovic I, Kovacs GG, Ferrer I, Perluigi M, Aronica E.
    Curr Alzheimer Res; 2017 Apr; 14(12):1305-1317. PubMed ID: 28720071
    [Abstract] [Full Text] [Related]

  • 24. Amyloid A4 protein and its precursor in Down's syndrome and Alzheimer's disease.
    Heinrich G.
    N Engl J Med; 1989 Oct 26; 321(17):1197. PubMed ID: 2571933
    [No Abstract] [Full Text] [Related]

  • 25. Noradrenaline in Alzheimer-type dementia and Down syndrome.
    Yates CM, Ritchie IM, Simpson J, Maloney AF, Gordon A.
    Lancet; 1981 Jul 04; 2(8236):39-40. PubMed ID: 6113408
    [No Abstract] [Full Text] [Related]

  • 26. Neurotransmitter deficits in Alzheimer's disease and in other dementing disorders.
    Mann DM, Yates PO.
    Hum Neurobiol; 1986 Jul 04; 5(3):147-58. PubMed ID: 2876973
    [Abstract] [Full Text] [Related]

  • 27. Concerns about using Zn supplementation in Down's syndrome (DS) children.
    Bucci I, Napolitano G, Giuliani C, Lio S, Minnucci A, Monaco F, Di Giacomo F, Calabrese G, Palka G, Sabatino G.
    Biol Trace Elem Res; 2001 Jul 04; 82(1-3):273-5. PubMed ID: 11697775
    [No Abstract] [Full Text] [Related]

  • 28. Decline in cerebral glucose utilisation and cognitive function with aging in Down's syndrome.
    Schapiro MB, Haxby JV, Grady CL, Duara R, Schlageter NL, White B, Moore A, Sundaram M, Larson SM, Rapoport SI.
    J Neurol Neurosurg Psychiatry; 1987 Jun 04; 50(6):766-74. PubMed ID: 2956363
    [Abstract] [Full Text] [Related]

  • 29. Characterization of Abeta11-40/42 peptide deposition in Alzheimer's disease and young Down's syndrome brains: implication of N-terminally truncated Abeta species in the pathogenesis of Alzheimer's disease.
    Liu K, Solano I, Mann D, Lemere C, Mercken M, Trojanowski JQ, Lee VM.
    Acta Neuropathol; 2006 Aug 04; 112(2):163-74. PubMed ID: 16865398
    [Abstract] [Full Text] [Related]

  • 30. [The probenecid test. Evaluation in clinical medicine of cerebral metabolism of serotonin and dopamine].
    Véron JP, Mérienne L.
    Nouv Presse Med; 1972 Feb 19; 1(8):537-9. PubMed ID: 4258943
    [No Abstract] [Full Text] [Related]

  • 31. Oxidative stress, poly(ADP)ribosylation and aging: in vitro studies on lymphocytes from normal and Down's syndrome subjects of different age and from patients with Alzheimer's dementia.
    Franceschi C, Monti D, Cossarizza A, Tomasi A, Sola P, Zannotti M.
    Adv Exp Med Biol; 1990 Feb 19; 264():499-502. PubMed ID: 2173880
    [No Abstract] [Full Text] [Related]

  • 32. Down syndrome as a key to the time sequence of brain changes in Alzheimer disease.
    Tagliavini F, Giaccone G, Verga L, Frangione B, Bugiani O.
    Prog Clin Biol Res; 1992 Feb 19; 379():143-58. PubMed ID: 1409741
    [No Abstract] [Full Text] [Related]

  • 33. Neurotrophins and dementia--keeping in touch.
    Castrén E, Tanila H.
    Neuron; 2006 Jul 06; 51(1):1-3. PubMed ID: 16815323
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. [Correlative study of the brain CT and clinical features of patients with Down's syndrome in three clinical stages of Alzheimer type dementia].
    Maruyama K, Ikeda S, Yanagisawa N.
    Rinsho Shinkeigaku; 1995 Jul 06; 35(7):775-80. PubMed ID: 8777802
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Exploring Alzheimer molecular pathology in Down's syndrome cerebrospinal fluid.
    Portelius E, Soininen H, Andreasson U, Zetterberg H, Persson R, Karlsson G, Blennow K, Herukka SK, Mattsson N.
    Neurodegener Dis; 2014 Jul 06; 14(2):98-106. PubMed ID: 24992945
    [Abstract] [Full Text] [Related]

  • 39. Cerebral oxygen consumption in Down's syndrome.
    Lassen NA, Christensen S, Hoedt-Rasmussen K, Stewart BM.
    Arch Neurol; 1966 Dec 06; 15(6):595-602. PubMed ID: 4224459
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.